SRTA R&D to Revenue
Strata Critical Medical Inc Class · R&D to Revenue
SRTA R&D to Revenue
Latest reported1.55%period ending
SRTA FY R&D/Revenue (2.41% → 1.55%)
Latest values, visible window
High-resolution chart · PNG
SRTA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 1.5481% | |
| 1.2803% | |
| 2.0548% | |
| 3.7948% | |
| 3.3329% | |
| 3.6741% | |
| 2.4074% |